The update of the Counter-Strike 2 skins exchange rules caused chaos. Some of the rare in-game items’ prices plummeted, stripping owners of the potential returns. The CS2 skins market cap dropped from $5.9 billion to $4.2 billion.  The trade-up contract…The update of the Counter-Strike 2 skins exchange rules caused chaos. Some of the rare in-game items’ prices plummeted, stripping owners of the potential returns. The CS2 skins market cap dropped from $5.9 billion to $4.2 billion.  The trade-up contract…

Counter-Strike 2 skins market takes a violent $1.7 billion hit overnight due to a game update

2025/10/25 00:55
4 min read
For feedback or concerns regarding this content, please contact us at [email protected]

The update of the Counter-Strike 2 skins exchange rules caused chaos. Some of the rare in-game items’ prices plummeted, stripping owners of the potential returns. The CS2 skins market cap dropped from $5.9 billion to $4.2 billion. 

Summary
  • In the first hour following the update, the prices for some of the in-game items declined by 40-60% on skin-trading platforms. 
  • Multiple gamers claimed they lost thousands of dollars in value due to the update. Other users, on the contrary, managed to sell previously cheap items for rare, costly knives.
  • Social media is filled with unsupported claims of insider trading and suicides caused by market volatility.
  • The situation is a hard lesson reminiscent of the one that once brought Vitalik Buterin to Bitcoin in his teen years.

The trade-up contract changes

The update was introduced by the game development company Valve on Oct. 22, 2025. The CS2 community anticipated it would be a usual bug-fixing patch, but on top of several minor improvements, it included serious changes to the game economy. 

The changes made to “Trade Up Contract” allow the exchange of five rare StatTrak™ items (with “Covert” status) for a single StatTrak™ knife from the collection of one of those five items. Five regular items can now be exchanged for one regular knife or a pair of gloves.

Before the update, people couldn’t exchange covert items for knives that had a higher rarity status. It created a value gap between items belonging to various rarity groups. An update aimed at democratizing the exchange of in-game items made some of the rare items less valuable. The reason is clear: now it is possible to exchange five cheap Covert items that cost $5–$10 for the knives that used to cost thousands of dollars. 

Allegedly, some of the rarest CS2 items used to be sold for hundreds of thousands of dollars. At some point, a Karambit Case Hardened Blue Gem knife owner allegedly turned down an offer of $1.2 million for his item. More than that, the knives that used to be scarce by design suddenly became less scarce as exchanging Covert items creates new knives.

The fallout

Many users began to complain that they lost a lot of money because their rare items got too cheap. Some claim they were earning through CS2 items, and now Valve has made their model not viable anymore. The number of affected players is hard to evaluate. According to various sources, the entire skins market cap was cut by nearly a third, losing $1.7 billion out of $5.9 billion.

One of the most scandalous outcomes is the rumors of multiple teens committing suicide in the fallout of the market turbulence. However, none of these claims has been confirmed. 

https://twitter.com/Pirat_Nation/status/1981511825364599065

The pictures of the Chinese police officers near one of the Universities circulating on social media, as the image related to suicide allegedly originated from earlier unrelated news reports.

Another concern voiced across the CS2 community is allegations of possible insider trading. Some speculate that the Valve team members or people familiar with the upcoming update sold their Covert items at a premium. However, these claims are not supported.

The spectrum of reactions

The reactions to the chaos are understandably negative, while the change in the rules is praised by some and hated by others.

Some of the commenters were favorable towards the changes made by Valve. Some were saying that they play CS2 not because of the financial incentives, and ridiculed those who suffered losses. One of the commenters on Steam claimed that the new update finally allowed them to get a knife for the first time. “Maybe now people will stop trying to launder money through skins,” the commenter said. 

The negative stance, however, is harsh. Some compare the situation to the biggest economic catastrophes of the recent past. For instance, one of the Steam users commented on the update post, calling the “Trade Up Contract” changes “the financial crisis 2008 equivalent, but for CS2.” 

The situation raised questions associated with trust in centralized entities as people felt they were “rugged” by Valve. Former YouTube gaming head, Ryan Wyatt, told The Gamer: 

The crypto community may find the case reminiscent of what brought teenage Vitalik Buterin into Bitcoin. The Ethereum creator said he first understood the power of decentralization when Blizzard Entertainment nerfed Buterin’s World of Warcraft character via a new update. 

No wonder Ethereum became one of the pioneering blockchains used for in-game items minting and exchange. If the CS2 economy were based on blockchain, insider trading would have been traceable. As of the press time, Valve has not responded to the community outcry.

Market Opportunity
SQUID MEME Logo
SQUID MEME Price(GAME)
$33.5361
$33.5361$33.5361
+0.43%
USD
SQUID MEME (GAME) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09